Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Trittel

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Review of Vaccines|August 14, 2015
Rodents as pre-clinical models for predicting vaccine performance in humansPeggy Riese, Stephanie Trittel, Kai Schulze, et al.
Expert Opinion on Drug Delivery|June 26, 2014
Intranasal formulations: promising strategy to deliver vaccinesPeggy Riese, Priya Sakthivel, Stephanie Trittel, et al.
Scientific Reports|November 10, 2019
Key features and homing properties of NK cells in the liver are shaped by activated iNKT cellsStephanie Trittel, Benedict J Chambers, Ulrike Heise, et al.
Frontiers in Immunology|April 7, 2018
Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR ExpressionNeha Vashist, Stephanie Trittel, Thomas Ebensen, et al.
Frontiers in Immunology|August 24, 2019
Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune InterventionStephanie Trittel, Neha Vashist, Thomas Ebensen, et al.
Vaccines|June 11, 2020
Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK CellsPeggy Riese, Stephanie Trittel, Rishi D Pathirana, et al.
European Journal of Immunology|March 27, 2015
Activated NKT cells imprint NK-cell differentiation, functionality and educationPeggy Riese, Stephanie Trittel, Tobias May, et al.
Ebiomedicine|July 30, 2017
Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation PathwayDarío Lirussi, Thomas Ebensen, Kai Schulze, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine DevelopmentDarío Lirussi, Thomas Ebensen, Kai Schulze, et al.
International Journal of Cancer|April 15, 2015
Induction of CD4(+) and CD8(+) anti-tumor effector T cell responses by bacteria mediated tumor therapyChristian Stern, Nadine Kasnitz, Dino Kocijancic, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|August 14, 2015
Rodents as pre-clinical models for predicting vaccine performance in humansPeggy Riese, Stephanie Trittel, Kai Schulze, et al.
Expert Opinion on Drug Delivery|June 26, 2014
Intranasal formulations: promising strategy to deliver vaccinesPeggy Riese, Priya Sakthivel, Stephanie Trittel, et al.
Scientific Reports|November 10, 2019
Key features and homing properties of NK cells in the liver are shaped by activated iNKT cellsStephanie Trittel, Benedict J Chambers, Ulrike Heise, et al.
Frontiers in Immunology|April 7, 2018
Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR ExpressionNeha Vashist, Stephanie Trittel, Thomas Ebensen, et al.
Frontiers in Immunology|August 24, 2019
Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune InterventionStephanie Trittel, Neha Vashist, Thomas Ebensen, et al.
Vaccines|June 11, 2020
Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK CellsPeggy Riese, Stephanie Trittel, Rishi D Pathirana, et al.
European Journal of Immunology|March 27, 2015
Activated NKT cells imprint NK-cell differentiation, functionality and educationPeggy Riese, Stephanie Trittel, Tobias May, et al.
Ebiomedicine|July 30, 2017
Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation PathwayDarío Lirussi, Thomas Ebensen, Kai Schulze, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine DevelopmentDarío Lirussi, Thomas Ebensen, Kai Schulze, et al.
International Journal of Cancer|April 15, 2015
Induction of CD4(+) and CD8(+) anti-tumor effector T cell responses by bacteria mediated tumor therapyChristian Stern, Nadine Kasnitz, Dino Kocijancic, et al.
Pageof 3